Supplementary Figure S2 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

Iseult M. Browne; Javier Pascual; Rosalind J. Cutts; Belinda Kingston; Sarah Hrebien; Lucy Suzanne Kilburn; Alex Pearson; Laura J. Moretti; Andrew M. Wardley; Iain R. Macpherson; Richard D. Baird; Rebecca Roylance; Miguel Gil‐Gil; Ángel L. Guerrero-Zotano; Isaac García-Murillas; Judith M. Bliss; Alistair E. Ring; Miguel Martín; Nicholas C. Turner

doi:10.1158/1078-0432.31006822

Supplementary Figure S2 from The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

2026 Open access

Read full text

Authors: Iseult M. Browne, Javier Pascual, Rosalind J. Cutts, Belinda Kingston, Sarah Hrebien, Lucy Suzanne Kilburn, Alex Pearson, Laura J. Moretti, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance

+7 more

Miguel Gil‐Gil, Ángel L. Guerrero-Zotano, Isaac García-Murillas, Judith M. Bliss, Alistair E. Ring, Miguel Martín, Nicholas C. Turner

DOI: 10.1158/1078-0432.31006822

Cited by: 0

Abstract

Variant Allele Fraction of CHIP genes at different timepoints

Fields of Study & Subjects

BRCA gene mutations in cancer Pituitary Gland Disorders and Treatments Breast Cancer Treatment Studies

Publication details

Publication date: 6 January 2026